Activation of D1/D5 Dopamine Receptors Protects Neurons from Synapse Dysfunction Induced by Amyloid-β Oligomers-Reference-Cited by-同舟云学术

Activation of D1/D5 Dopamine Receptors Protects Neurons from Synapse Dysfunction Induced by Amyloid-β Oligomers

Published:2011-02 Issue:5 Volume:286 Page:3270-3276
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Jürgensen Sofia,Antonio Leandro L.,Mussi Gabriela E.A.,Brito-Moreira Jordano,Bomfim Theresa R.,De Felice Fernanda G.,Garrido-Sanabria Emilio R.,Cavalheiro Ésper A.,Ferreira Sergio T.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference62 articles.

1. Forecasting the global burden of Alzheimer's disease

2. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

3. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

4. Diffusible, nonfibrillar ligands derived from A 1-42 are potent central nervous system neurotoxins

5. Soluble protein oligomers as emerging toxins in alzheimer's and other amyloid diseases

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer’s Disease;Molecular Psychiatry;2024-01-16

2. DAT1 and BDNF polymorphisms interact to predict Aβ and tau pathology;Neurobiology of Aging;2024-01

3. AAV-mediated neuronal expression of an scFv antibody selective for Aβ oligomers protects synapses and rescues memory in Alzheimer models;Molecular Therapy;2023-02

4. The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease;Frontiers in Psychiatry;2022-10-17

5. Cognitive Impairment in Alzheimer’s and Metabolic Diseases: A Catecholaminergic Hypothesis;Neuroscience;2022-08